Mercury Laboratories Limited (BOM:538964)

India · Delayed Price · Currency is INR

730.00

-81.00 (-9.99%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals Products	751.01M	755.59M	753.34M	579.24M	686.02M
Pharmaceuticals Products Growth	-0.61%	0.30%	30.06%	-15.56%	19.79%
Total	751.01M	755.59M	753.34M	579.24M	686.02M
Total Growth	-0.61%	0.30%	30.06%	-15.56%	19.79%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	542.58M	568.48M	562.57M	483.94M	504.81M
India Growth	-4.56%	1.05%	16.25%	-4.13%	5.33%
Export	208.43M	187.11M	190.77M	95.30M	-
Export Growth	11.39%	-1.92%	100.18%	-	-
United Kingdom	-	-	-	-	181.21M
United Kingdom Growth	-	-	-	-	4753.41%
Total	751.01M	755.59M	753.34M	579.24M	686.02M
Total Growth	-0.61%	0.30%	30.06%	-15.56%	19.79%

Source: S&P Global Market Intelligence.